Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Trauma and psychedelic-assisted therapy

PS2023-259-tn

Trauma and psychedelic-assisted therapy

Dr. Barbara Rothbaum has been researching and delivering evidence-based treatment (EBT) for PTSD since 1986. In this talk, she will enumerate the advantages of combining MDMA with prolonged exposure therapy (PE) for PTSD. PE is a well-studied, effective, well disseminated EBT with many PE trainers worldwide. PE is recommended as a first-line treatment in every published treatment guideline for PTSD. There is theoretical support for a synergistic mechanism of action for adding MDMA to PE. Translational research supports that MDMA facilitates the extinction of fear in a rodent model. In a healthy human model, more extinction recall responders were in the MDMA condition.

Share: Trauma and psychedelic-assisted therapy

Facebook
Twitter
LinkedIn
Email

Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.

Report an Error

The PS2023: The Virtual Trip team has worked hard to create session captions, transcripts, and web pages as accurately as possible, but we know that some errors may have made it past our review process. Let us know what needs to be fixed! Please provide the session name and/or page URL where you found the error, the time the error occurs (if in a video), and the correct information we should use to fix the error. We appreciate your help in making PS2023: The Virtual Trip even better!

Name
Hidden
This field is for validation purposes and should be left unchanged.